# Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

> **NCT00596102** · — · COMPLETED · sponsor: **Valneva Austria GmbH** · enrollment: 3258 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Japanese Encephalitis purified inactivated vaccine

## Key facts

- **NCT ID:** NCT00596102
- **Lead sponsor:** Valneva Austria GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2011-03
- **Final completion:** —
- **Target enrollment:** 3258 (ACTUAL)
- **Last updated:** 2014-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596102, "Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00596102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*